263 related articles for article (PubMed ID: 24763974)
1. Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B.
Athale AH; Marcucci M; Iorio A
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010561. PubMed ID: 24763974
[TBL] [Abstract][Full Text] [Related]
2. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B.
Olasupo OO; Lowe MS; Krishan A; Collins P; Iorio A; Matino D
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014201. PubMed ID: 34407214
[TBL] [Abstract][Full Text] [Related]
5. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011385. PubMed ID: 31002742
[TBL] [Abstract][Full Text] [Related]
6. Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery.
Coppola A; Windyga J; Tufano A; Yeung C; Di Minno MN
Cochrane Database Syst Rev; 2015 Feb; (2):CD009961. PubMed ID: 25922858
[TBL] [Abstract][Full Text] [Related]
7. Bypassing agent prophylaxis in people with hemophilia A or B with inhibitors.
Chai-Adisaksopha C; Nevitt SJ; Simpson ML; Janbain M; Konkle BA
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011441. PubMed ID: 28944952
[TBL] [Abstract][Full Text] [Related]
8. Non-clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B.
Olasupo OO; Noronha N; Lowe MS; Ansel D; Bhatt M; Matino D
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD014544. PubMed ID: 38411279
[TBL] [Abstract][Full Text] [Related]
9. Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors.
Matino D; Makris M; Dwan K; D'Amico R; Iorio A
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD004449. PubMed ID: 26677005
[TBL] [Abstract][Full Text] [Related]
10. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
Iorio A; Marchesini E; Marcucci M; Stobart K; Chan AK
Cochrane Database Syst Rev; 2011 Sep; (9):CD003429. PubMed ID: 21901684
[TBL] [Abstract][Full Text] [Related]
11. Antifibrinolytic therapy for preventing oral bleeding in people on anticoagulants undergoing minor oral surgery or dental extractions.
Engelen ET; Schutgens RE; Mauser-Bunschoten EP; van Es RJ; van Galen KP
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012293. PubMed ID: 29963686
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy for haemophilia.
Sharma A; Easow Mathew M; Sriganesh V; Neely JA; Kalipatnapu S
Cochrane Database Syst Rev; 2014 Nov; (11):CD010822. PubMed ID: 25394678
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy for haemophilia.
Sharma A; Easow Mathew M; Sriganesh V; Reiss UM
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD010822. PubMed ID: 32342499
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors.
Iorio A; Matino D; D'Amico R; Makris M
Cochrane Database Syst Rev; 2010 Aug; (8):CD004449. PubMed ID: 20687076
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for haemophilia.
Sharma A; Easow Mathew M; Sriganesh V; Reiss UM
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010822. PubMed ID: 27996087
[TBL] [Abstract][Full Text] [Related]
16. Rituximab for treating inhibitors in people with inherited severe hemophilia.
Jiang L; Liu Y; Zhang L; Santoro C; Rodriguez A
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD010810. PubMed ID: 28685500
[TBL] [Abstract][Full Text] [Related]
17. Rituximab for treating inhibitors in people with inherited severe hemophilia.
Jiang L; Liu Y; Zhang L; Santoro C; Rodriguez A
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD010810. PubMed ID: 32761818
[TBL] [Abstract][Full Text] [Related]
18. Rituximab for treating inhibitors in people with inherited severe hemophilia.
Liu Y; Zhang L; Santoro C; Song J; Rodriguez A; Wang L
Cochrane Database Syst Rev; 2015 Apr; (4):CD010810. PubMed ID: 25841099
[TBL] [Abstract][Full Text] [Related]
19. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
Stobart K; Iorio A; Wu JK
Cochrane Database Syst Rev; 2006 Apr; (2):CD003429. PubMed ID: 16625581
[TBL] [Abstract][Full Text] [Related]
20. Exercise for haemophilia.
Strike K; Mulder K; Michael R
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD011180. PubMed ID: 27992070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]